1. Home
  2. JBI vs PHAT Comparison

JBI vs PHAT Comparison

Compare JBI & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Janus International Group Inc.

JBI

Janus International Group Inc.

SELL

Current Price

$4.10

Market Cap

697.2M

Sector

Industrials

ML Signal

SELL

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

SELL

Current Price

$7.40

Market Cap

590.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
JBI
PHAT
Founded
2002
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
697.2M
590.6M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
JBI
PHAT
Price
$4.10
$7.40
Analyst Decision
Buy
Buy
Analyst Count
5
12
Target Price
$7.62
★ $20.09
AVG Volume (30 Days)
★ 2.1M
1.3M
Earning Date
11-05-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 42.72
EPS
★ 0.08
N/A
Revenue
N/A
★ $175,110,000.00
Revenue This Year
$5.29
$80.58
Revenue Next Year
$2.62
$56.62
P/E Ratio
$53.50
★ N/A
Revenue Growth
N/A
★ 216.93
52 Week Low
$4.01
$6.52
52 Week High
$10.32
$18.31

Technical Indicators

Market Signals
Indicator
JBI
PHAT
Relative Strength Index (RSI) 38.18 47.21
Support Level $4.01 $6.91
Resistance Level $4.41 $9.74
Average True Range (ATR) 0.16 0.34
MACD 0.02 0.10
Stochastic Oscillator 18.75 74.58

Price Performance

Historical Comparison
JBI
PHAT

About JBI Janus International Group Inc.

Janus International Group Inc is a manufacturer and supplier of turnkey solutions for self-storage, commercial, and industrial building Solutions. It provides products that include roll-up and swing doors, hallway systems, relocatable storage MASS (Moveable Additional Storage Structures) units, and technologies for automating facility and door operation. It is operated through two geographic regions; Janus North America and Janus International. The Janus International segment is comprised of a subsidiary whose production and sales are largely in Europe and Australia. The Janus North America segment is comprised of all the other entities.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: